Economy

Buffett to sit alongside board members at 2026 Berkshire meeting, won’t appear on stage, report says

Warren Buffett to Skip Stage Appearance at 2026 Berkshire Hathaway Shareholders' Meeting (Reuters) - Berkshire Hathaway founder and chairman Warren Buffett has decided to forgo his usual stage appearance at

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Economy

Precious Metals Rally Extends As Safe Haven Demand Surges

The safe-haven trade in precious metals continues to gain momentum, with gold, silver, and platinum all seeing extended gains in

Janus Henderson Group (JHG) Target Reset After $7.4B Take-Private Deal

Janus Henderson Group plc (NYSE:JHG) has recently made headlines as one of the 13 Best Debt Free Dividend Stocks to

5 Artificial Intelligence (AI) Stocks to Own Through 2035

Artificial intelligence (AI) investments are paving the way for a potentially lucrative market that could reach trillions of dollars by

How To Earn $500 A Month From Micron Stock

Micron Technology Inc (NASDAQ: MU) saw its shares reach a new all-time high on Wednesday before experiencing a slight pullback.

6 mistakes can quietly drain your retirement savings.How to enjoy smoother sailing in retirement

Retirement planning is a crucial aspect of financial security in your later years. Most retirement advice emphasizes the importance of

The most creative money-saving strategies we heard from super savers and early retirees in 2025

Business Insider has had the opportunity to interview numerous super savers, early retirees, and financially independent investors. These individuals have

Will a Santa Claus Rally Set Up a Strong 2026? Here’s My Take on the Year-End Window.

The Santa Claus rally is a well-known phenomenon in the stock market, occurring 80% of the time during the last

Forget Moderna Stock, This is a Much Better Buy

Investors were quick to jump on the Moderna (NASDAQ: MRNA) bandwagon during the early days of the pandemic, driven by